ARCHIVES

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Other DCT Concepts Approved By BSC

June 6, 1986

Review Of DCCR Programs Uncovers Problems, Assigns Scores To Each

June 30, 1978

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014